Global Antibody-drug Conjugates Market Insights and Forecast to 2027

Global Antibody-drug Conjugates Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Antibody-drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type
1.4.2 Adcetris
1.4.3 Kadcyla
1.3 Market by Application
1.3.1 Global Antibody-drug Conjugates Market Size Growth Rate by Application
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts 2016-2027
2.2 Global Antibody-drug Conjugates Revenue Estimates and Forecasts 2016-2027
2.3 Global Antibody-drug Conjugates Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Antibody-drug Conjugates Regions by Sales
2.4.1 Global Top Antibody-drug Conjugates Regions by Sales (2016-2021)
2.4.2 Global Top Antibody-drug Conjugates Regions by Sales (2022-2027)
2.5 Global Top Antibody-drug Conjugates Regions by Revenue
2.5.1 Global Top Antibody-drug Conjugates Regions by Revenue (2016-2021)
2.5.2 Global Top Antibody-drug Conjugates Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibody-drug Conjugates Sales by Manufacturers
3.1.1 Global Top Antibody-drug Conjugates Manufacturers by Sales (2016-2021)
3.1.2 Global Top Antibody-drug Conjugates Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Sales in 2020
3.2 Global Antibody-drug Conjugates Revenue by Manufacturers
3.2.1 Global Top Antibody-drug Conjugates Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Antibody-drug Conjugates Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Revenue in 2020
3.3 Global Antibody-drug Conjugates Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibody-drug Conjugates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibody-drug Conjugates Sales by Type
4.1.1 Global Antibody-drug Conjugates Historical Sales by Type (2016-2021)
4.1.2 Global Antibody-drug Conjugates Forecasted Sales by Type (2022-2027)
4.1.3 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
4.2 Global Antibody-drug Conjugates Revenue by Type
4.2.1 Global Antibody-drug Conjugates Historical Revenue by Type (2016-2021)
4.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Type (2022-2027)
4.2.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
4.3 Global Antibody-drug Conjugates Price by Type
4.3.1 Global Antibody-drug Conjugates Price by Type (2016-2021)
4.3.2 Global Antibody-drug Conjugates Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Antibody-drug Conjugates Sales by Application
5.1.1 Global Antibody-drug Conjugates Historical Sales by Application (2016-2021)
5.1.2 Global Antibody-drug Conjugates Forecasted Sales by Application (2022-2027)
5.1.3 Global Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
5.2 Global Antibody-drug Conjugates Revenue by Application
5.2.1 Global Antibody-drug Conjugates Historical Revenue by Application (2016-2021)
5.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Application (2022-2027)
5.2.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
5.3 Global Antibody-drug Conjugates Price by Application
5.3.1 Global Antibody-drug Conjugates Price by Application (2016-2021)
5.3.2 Global Antibody-drug Conjugates Price Forecast by Application (2022-2027)
6 North America
6.1 North America Antibody-drug Conjugates Market Size by Type
6.1.1 North America Antibody-drug Conjugates Sales by Type (2016-2027)
6.1.2 North America Antibody-drug Conjugates Revenue by Type (2016-2027)
6.2 North America Antibody-drug Conjugates Market Size by Application
6.2.1 North America Antibody-drug Conjugates Sales by Application (2016-2027)
6.2.2 North America Antibody-drug Conjugates Revenue by Application (2016-2027)
6.3 North America Antibody-drug Conjugates Market Size by Country
6.3.1 North America Antibody-drug Conjugates Sales by Country (2016-2027)
6.3.2 North America Antibody-drug Conjugates Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibody-drug Conjugates Market Size by Type
7.1.1 Europe Antibody-drug Conjugates Sales by Type (2017-2027)
7.1.2 Europe Antibody-drug Conjugates Revenue by Type (2017-2027)
7.2 Europe Antibody-drug Conjugates Market Size by Application
7.2.1 Europe Antibody-drug Conjugates Sales by Application (2017-2027)
7.2.2 Europe Antibody-drug Conjugates Revenue by Application (2017-2027)
7.3 Europe Antibody-drug Conjugates Market Size by Country
7.3.1 Europe Antibody-drug Conjugates Sales by Country (2017-2027)
7.3.2 Europe Antibody-drug Conjugates Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody-drug Conjugates Market Size by Type
8.1.1 Asia Pacific Antibody-drug Conjugates Sales by Type (2018-2027)
8.1.2 Asia Pacific Antibody-drug Conjugates Revenue by Type (2018-2027)
8.2 Asia Pacific Antibody-drug Conjugates Market Size by Application
8.2.1 Asia Pacific Antibody-drug Conjugates Sales by Application (2018-2027)
8.2.2 Asia Pacific Antibody-drug Conjugates Revenue by Application (2018-2027)
8.3 Asia Pacific Antibody-drug Conjugates Market Size by Region
8.3.1 Asia Pacific Antibody-drug Conjugates Sales by Region (2018-2027)
8.3.2 Asia Pacific Antibody-drug Conjugates Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibody-drug Conjugates Market Size by Type
9.1.1 Latin America Antibody-drug Conjugates Sales by Type (2019-2027)
9.1.2 Latin America Antibody-drug Conjugates Revenue by Type (2019-2027)
9.2 Latin America Antibody-drug Conjugates Market Size by Application
9.2.1 Latin America Antibody-drug Conjugates Sales by Application (2019-2027)
9.2.2 Latin America Antibody-drug Conjugates Revenue by Application (2019-2027)
9.3 Latin America Antibody-drug Conjugates Market Size by Country
9.3.1 Latin America Antibody-drug Conjugates Sales by Country (2019-2027)
9.3.2 Latin America Antibody-drug Conjugates Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Antibody-drug Conjugates Market Size by Type
6.1.1 Middle East and Africa Antibody-drug Conjugates Sales by Type (2016-2027)
6.1.2 Middle East and Africa Antibody-drug Conjugates Revenue by Type (2016-2027)
6.2 Middle East and Africa Antibody-drug Conjugates Market Size by Application
6.2.1 Middle East and Africa Antibody-drug Conjugates Sales by Application (2016-2027)
6.2.2 Middle East and Africa Antibody-drug Conjugates Revenue by Application (2016-2027)
6.3 Middle East and Africa Antibody-drug Conjugates Market Size by Country
6.3.1 Middle East and Africa Antibody-drug Conjugates Sales by Country (2016-2027)
6.3.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 ImmunoGen
11.1.1 ImmunoGen Corporation Information
11.1.2 ImmunoGen Overview
11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 ImmunoGen Antibody-drug Conjugates Product Description
11.1.5 ImmunoGen Related Developments
11.2 Seattle Genetics
11.2.1 Seattle Genetics Corporation Information
11.2.2 Seattle Genetics Overview
11.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Seattle Genetics Antibody-drug Conjugates Product Description
11.2.5 Seattle Genetics Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Roche Antibody-drug Conjugates Product Description
11.3.5 Roche Related Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Overview
11.4.3 Takeda Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Takeda Antibody-drug Conjugates Product Description
11.4.5 Takeda Related Developments
11.1 ImmunoGen
11.1.1 ImmunoGen Corporation Information
11.1.2 ImmunoGen Overview
11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 ImmunoGen Antibody-drug Conjugates Product Description
11.1.5 ImmunoGen Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Antibody-drug Conjugates Value Chain Analysis
12.2 Antibody-drug Conjugates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody-drug Conjugates Production Mode & Process
12.4 Antibody-drug Conjugates Sales and Marketing
12.4.1 Antibody-drug Conjugates Sales Channels
12.4.2 Antibody-drug Conjugates Distributors
12.5 Antibody-drug Conjugates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibody-drug Conjugates Industry Trends
13.2 Antibody-drug Conjugates Market Drivers
13.3 Antibody-drug Conjugates Market Challenges
13.4 Antibody-drug Conjugates Market Restraints
14 Key Findings in The Global Antibody-drug Conjugates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Adcetris
Table 3. Major Manufacturers of Kadcyla
Table 4. Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Antibody-drug Conjugates Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)
Table 7. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
Table 8. Global Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)
Table 9. Global Antibody-drug Conjugates Sales Market Share by Region (2022-2027)
Table 10. Global Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)
Table 12. Global Antibody-drug Conjugates Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Antibody-drug Conjugates Revenue Market Share by Region (2022-2027)
Table 14. Global Antibody-drug Conjugates Sales by Manufacturers (2016-2021) & (Kg)
Table 15. Global Antibody-drug Conjugates Sales Share by Manufacturers (2016-2021)
Table 16. Global Antibody-drug Conjugates Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2016-2021)
Table 18. Antibody-drug Conjugates Price by Manufacturers 2016-2021 (USD/Kg)
Table 19. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2020)
Table 21. Antibody-drug Conjugates Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antibody-drug Conjugates Product Offered
Table 23. Date of Manufacturers Enter into Antibody-drug Conjugates Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 26. Global Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 27. Global Antibody-drug Conjugates Sales Share by Type (2016-2021)
Table 28. Global Antibody-drug Conjugates Sales Share by Type (2022-2027)
Table 29. Global Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Antibody-drug Conjugates Revenue Share by Type (2016-2021)
Table 32. Global Antibody-drug Conjugates Revenue Share by Type (2022-2027)
Table 33. Antibody-drug Conjugates Price by Type (2016-2021) & (USD/Kg)
Table 34. Global Antibody-drug Conjugates Price Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 36. Global Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 37. Global Antibody-drug Conjugates Sales Share by Application (2016-2021)
Table 38. Global Antibody-drug Conjugates Sales Share by Application (2022-2027)
Table 39. Global Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Antibody-drug Conjugates Revenue Share by Application (2016-2021)
Table 42. Global Antibody-drug Conjugates Revenue Share by Application (2022-2027)
Table 43. Antibody-drug Conjugates Price by Application (2016-2021) & (USD/Kg)
Table 44. Global Antibody-drug Conjugates Price Forecast by Application (2022-2027) & (USD/Kg)
Table 45. North America Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 46. North America Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 47. North America Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 50. North America Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 51. North America Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 54. North America Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg)
Table 55. North America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 58. Europe Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 59. Europe Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 62. Europe Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 63. Europe Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 66. Europe Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg)
Table 67. Europe Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 70. Asia Pacific Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 71. Asia Pacific Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 74. Asia Pacific Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 75. Asia Pacific Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)
Table 78. Asia Pacific Antibody-drug Conjugates Sales by Region (2022-2027) & (Kg)
Table 79. Asia Pacific Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Antibody-drug Conjugates Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 82. Latin America Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 83. Latin America Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 86. Latin America Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 87. Latin America Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 90. Latin America Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg)
Table 91. Latin America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 94. Middle East and Africa Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 95. Middle East and Africa Antibody-drug Conjugates Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Antibody-drug Conjugates Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 98. Middle East and Africa Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 99. Middle East and Africa Antibody-drug Conjugates Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Antibody-drug Conjugates Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
Table 102. Middle East and Africa Antibody-drug Conjugates Sales by Country (2022-2027) & (Kg)
Table 103. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2022-2027) & (US$ Million)
Table 105. ImmunoGen Corporation Information
Table 106. ImmunoGen Description and Major Businesses
Table 107. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 108. ImmunoGen Antibody-drug Conjugates Product
Table 109. ImmunoGen Recent Developments
Table 110. Seattle Genetics Corporation Information
Table 111. Seattle Genetics Description and Major Businesses
Table 112. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Seattle Genetics Antibody-drug Conjugates Product
Table 114. Seattle Genetics Recent Developments
Table 115. Roche Corporation Information
Table 116. Roche Description and Major Businesses
Table 117. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Roche Antibody-drug Conjugates Product
Table 119. Roche Recent Developments
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Major Businesses
Table 122. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Takeda Antibody-drug Conjugates Product
Table 124. Takeda Recent Developments
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Antibody-drug Conjugates Distributors List
Table 128. Antibody-drug Conjugates Customers List
Table 129. Antibody-drug Conjugates Market Trends
Table 130. Antibody-drug Conjugates Market Drivers
Table 131. Antibody-drug Conjugates Market Challenges
Table 132. Antibody-drug Conjugates Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Market Share by Type in 2020 & 2027
Figure 3. Adcetris Product Picture
Figure 4. Kadcyla Product Picture
Figure 5. Global Antibody-drug Conjugates Sales Market Share by Application in 2020 & 2027
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Antibody-drug Conjugates Report Years Considered
Figure 9. Global Antibody-drug Conjugates Sales 2016-2027 (Kg)
Figure 10. Global Antibody-drug Conjugates Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Antibody-drug Conjugates Revenue 2016-2027 (US$ Million)
Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
Figure 14. Global Antibody-drug Conjugates Sales Market Share by Region (2022-2027)
Figure 15. North America Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg)
Figure 16. North America Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg)
Figure 18. Europe Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg)
Figure 20. Asia-Pacific Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg)
Figure 22. Latin America Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Antibody-drug Conjugates Sales YoY (2016-2027) & (Kg)
Figure 24. Middle East & Africa Antibody-drug Conjugates Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Antibody-drug Conjugates Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Antibody-drug Conjugates Revenue in 2020
Figure 27. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
Figure 29. Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
Figure 30. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
Figure 31. Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
Figure 32. North America Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
Figure 33. North America Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
Figure 34. North America Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
Figure 35. North America Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
Figure 36. North America Antibody-drug Conjugates Sales Share by Country (2016-2027)
Figure 37. North America Antibody-drug Conjugates Revenue Share by Country (2016-2027)
Figure 38. U.S. Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
Figure 41. Europe Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
Figure 42. Europe Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
Figure 43. Europe Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
Figure 44. Europe Antibody-drug Conjugates Sales Share by Country (2016-2027)
Figure 45. Europe Antibody-drug Conjugates Revenue Share by Country (2016-2027)
Figure 46. Germany Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 47. France Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Antibody-drug Conjugates Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Antibody-drug Conjugates Revenue Share by Region (2016-2027)
Figure 57. China Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 60. India Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 62. Taiwan Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 66. Philippines Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
Figure 68. Latin America Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
Figure 70. Latin America Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Antibody-drug Conjugates Sales Share by Country (2016-2027)
Figure 72. Latin America Antibody-drug Conjugates Revenue Share by Country (2016-2027)
Figure 73. Mexico Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Antibody-drug Conjugates Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Antibody-drug Conjugates Revenue Share by Country (2016-2027)
Figure 82. Turkey Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 84. U.A.E Antibody-drug Conjugates Revenue (2016-2027) & (US$ Million)
Figure 85. Antibody-drug Conjugates Value Chain
Figure 86. Antibody-drug Conjugates Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs